NUKK · Nukkleus Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $21.51M | $19.20M | - | - | - | - |
| Cost of Revenue | $22.17M | $18.90M | - | $18.90M | $18.90M | $9.58M |
| Gross Profit | ($661.4K) | $94.0K | $300.0K | $300.0K | $300.0K | $300.0K |
| R&D | - | - | - | - | - | - |
| SG&A | - | - | - | - | $455.8K | $289.7K |
| Total Operating Expenses | $10.48M | $1.03M | $413.1K | $1.06M | $476.8K | $412.7K |
| D&A | $2.69M | $469.3K | - | - | - | - |
| Operating Income | ($11.14M) | ($932.4K) | ($113.1K) | ($755.8K) | ($176.8K) | ($112.7K) |
| Interest Expense | - | - | - | - | $35.4K | $7.9K |
| Income Tax | - | - | - | - | - | - |
| Net Income | ($11.85M) | ($936.8K) | ($100.6K) | ($730.1K) | ($212.2K) | ($136.9K) |
| EPS - Basic | ($0.03) | $0.00 | - | - | $0.00 | $0.00 |
| EPS - Diluted | ($0.02) | $0.00 | - | - | - | $0.00 |
Balance Sheet
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $364.0K | $355.7K | $82.8K | $23.5K | $257.6K | $48.6K |
| Accounts Receivable | - | $58.0K | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $51.7K | $54.8K | - | - | - | - |
| Current Assets | $3.69M | $3.04M | $3.80M | $203.0K | $305.8K | $1.10M |
| Total Assets | $18.36M | $16.66M | $3.80M | $203.0K | $305.8K | $1.10M |
| Current Liabilities | $7.47M | $4.64M | $5.19M | $1.25M | $625.4K | $434.4K |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $7.47M | $4.64M | $5.19M | $1.50M | $869.3K | $1.40M |
| Stockholders' Equity | $10.89M | $12.02M | ($1.39M) | ($1.29M) | ($563.5K) | ($351.3K) |
| Retained Earnings | ($14.34M) | ($2.50M) | ($1.56M) | ($1.46M) | ($727.6K) | ($515.5K) |
Cash Flow
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.62M | $295.9K | $59.3K | ($138.4K) | ($1.0K) | $48.6K |
| Investing Cash Flow | ($35.0K) | ($23.3K) | - | ($95.7K) | $960.0K | ($1.00M) |
| Financing Cash Flow | - | - | - | - | ($750.0K) | $1.00M |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | -3.1% | 0.5% | - | - | - | - |
| Operating margin | -51.8% | -4.9% | - | - | - | - |
| EBITDA margin | -39.3% | -2.4% | - | - | - | - |
| Net margin | -55.1% | -4.9% | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -64.5% | -5.6% | -2.6% | -359.7% | -69.4% | -12.4% |
| Return on equity | -108.8% | -7.8% | 7.2% | 56.4% | 37.7% | 39.0% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 0.49 | 0.66 | 0.73 | 0.16 | 0.49 | 2.54 |
| Quick ratio | 0.49 | 0.66 | 0.73 | 0.16 | 0.49 | 2.54 |
| Cash ratio | 0.05 | 0.08 | 0.02 | 0.02 | 0.41 | 0.11 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | -5.0x | -14.4x |
| Equity multiplier | 1.69 | 1.39 | -2.73 | -0.16 | -0.54 | -3.14 |
| Liabilities / Assets | 0.41 | 0.28 | 1.37 | 7.37 | 2.84 | 1.27 |
| Efficiency | ||||||
| Asset turnover | 1.17 | 1.15 | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | 1d | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | 1d | 1d | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 12.0% | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | -68.7% | 0.0% | 0.0% | 0.0% | 147.4% |
| Operating income growth (YoY) | -1095.0% | -724.3% | 85.0% | -327.5% | -56.9% | 55.4% |
| Net income growth (YoY) | -1164.4% | -831.6% | 86.2% | -244.1% | -55.0% | - |
| EPS growth (YoY) | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -9.4% | - | -7.8% | -129.6% | -60.4% | -48.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-09-30.
Business segments
$19.29M totalGeneral Support Services$19.20M · 99.5%
Financial Services$87.0K · 0.5%
Stability scores
Altman Z′
FY 2022 · bankruptcy risk
-0.91
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2022 · 9-point quality
3/9
Weak
- ✗Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Management Consulting Services
Comparing Nukkleus Inc. against the 5 most active filers in the same SIC group.